These findings suggest that HOXB13 KD may enhance cell motility primarily through MMP-mediated disruption of the extracellular matrix (ECM), rather than by broadly increasing PCa cell plasticity through EMT. The gene discussed is HOXB13; the disease is posterior cortical atrophy.